Luke Sergott Analyst PerformanceDirector at BarclaysLuke Sergott is a stock analyst at Barclays, covering 25 publicly traded companies across a range of sectors. Over the past year, Luke Sergott has issued 55 stock ratings, including buy, hold, and sell recommendations. While full access to Luke Sergott's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Luke Sergott's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings57 Last 5 YearsBuy Recommendations56.14% 32 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution57RatingsDistribution of strong buy, buy, hold, and sell ratings by Luke Sergott.RatingPercentageCount Strong Buy0.0%0 ratings Buy56.1%32 ratings Hold38.6%22 ratings Sell5.3%3 ratingsOut of 57 total stock ratings issued by Luke Sergott at Barclays, the majority (56.1%) have been Buy recommendations, followed by 38.6% Hold and 5.3% Sell.Best & Worst CallsBest Call000.0%TXGDec 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TWSTFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ60.0% of companies on NASDAQ15 companiesNYSE40.0% of companies on NYSE10 companiesLuke Sergott, an analyst at Barclays, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical24 companies96.0%Computer and Technology1 company4.0%Luke Sergott of Barclays specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE9 companies36.0%MEDICAL SERVICES7 companies28.0%MED INSTRUMENTS5 companies20.0%MED PRODUCTS1 company4.0%MEDICAL INFO SYS1 company4.0%INSTRU - SCIENTFC1 company4.0%MED/DENTAL - SUPP1 company4.0% About Luke SergottExperienced healthcare analyst with a focus in public and private Life Sciences and Diagnostics companies. Follow on LinkedIn Luke Sergott's Ratings History at Barclays Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAAgilent Technologies8/29/2025Reiterated Rating$124.70$125.00Equal Weight$0.0000.00% ROINTRANatera8/8/2025Reiterated Rating$141.08$210.00Overweight$0.0000.00% ROITXG10x Genomics8/8/2025Reiterated Rating$12.80$15.00Overweight$0.0000.00% ROIFTREFortrea8/7/2025Reiterated Rating$6.58$6.00Underweight$0.0000.00% ROIEXASExact Sciences8/7/2025Lower Price Target$46.91$55.00Overweight$0.0000.00% ROICRLCharles River Laboratories International8/7/2025Boost Price Target$150.60$165.00Equal Weight$0.0000.00% ROIAVTRAvantor8/4/2025Reiterated Rating$11.46$13.00Overweight$0.0000.00% ROIBRKRBruker8/4/2025Lower Price Target$34.72$43.00Overweight$0.0000.00% ROIINCYIncyte8/1/2025Initiated Coverage$74.89$90.00Overweight$0.0000.00% ROIILMNIllumina8/1/2025Boost Price Target$97.65$90.00Underweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ICLRIcon7/25/2025Boost Price Target$186.16$180.00Equal Weight$0.0000.00% ROITMOThermo Fisher Scientific7/24/2025Boost Price Target$466.84$490.00Equal Weight$0.0000.00% ROIMEDPMedpace7/23/2025Boost Price Target$477.73$450.00Equal Weight$0.0000.00% ROIIQVIQVIA7/23/2025Boost Price Target$187.89$185.00Equal Weight$0.0000.00% ROIPACBPacific Biosciences of California6/25/2025Lower Price Target$1.18$1.50Equal Weight$0.0000.00% ROIMEDPMedpace6/24/2025Initiated Coverage$308.64$300.00Equal Weight$0.0000.00% ROIMTDMettler-Toledo International6/24/2025Initiated Coverage$1,164.53$1,325.00Overweight$0.0000.00% ROIQGENQiagen6/24/2025Initiated Coverage$46.72$55.00Overweight$0.0000.00% ROIRGENRepligen6/24/2025Initiated Coverage$120.11$150.00Overweight$0.0000.00% ROIWSTWest Pharmaceutical Services6/24/2025Initiated Coverage$217.05$245.00Equal Weight$0.0000.00% ROITXG10x Genomics6/24/2025Reiterated Rating$10.94$13.00Overweight$0.0000.00% ROITMOThermo Fisher Scientific6/24/2025Lower Price Target$401.19$450.00Equal Weight$0.0000.00% ROISHCSotera Health6/24/2025Lower Price Target$11.20$13.00Overweight$0.0000.00% ROICERTCertara5/8/2025Upgrade$11.46$14.00Overweight$0.0000.00% ROICRLCharles River Laboratories International5/8/2025Boost Price Target$141.77$155.00Equal Weight$0.0000.00% ROIBRKRBruker5/8/2025Lower Price Target$42.13$46.00Overweight$0.0000.00% ROIAVTRAvantor4/28/2025Lower Price Target$12.93$15.00Overweight$0.0000.00% ROISHCSotera Health4/10/2025Lower Price Target$10.61$12.00Overweight$0.0000.00% ROIIQVIQVIA4/10/2025Reiterated Rating$157.02$170.00Equal Weight$0.0000.00% ROIICLRIcon4/10/2025Reiterated Rating$155.49$165.00Equal Weight$0.0000.00% ROIFTREFortrea4/10/2025Reiterated Rating$6.45$6.00Underweight$0.0000.00% ROIDHRDanaher4/10/2025Upgrade$192.18$205.00Overweight$0.0000.00% ROICRLCharles River Laboratories International4/10/2025Lower Price Target$128.77$145.00Equal Weight$0.0000.00% ROICERTCertara4/10/2025Lower Price Target$9.02$11.00Equal Weight$0.0000.00% ROIAVTRAvantor4/10/2025Lower Price Target$14.97$18.00Overweight$0.0000.00% ROITXG10x Genomics4/10/2025Lower Price Target$7.81$12.00Overweight$0.0000.00% ROITWSTTwist Bioscience4/10/2025Lower Price Target$35.90$45.00Overweight$0.0000.00% ROITMOThermo Fisher Scientific4/10/2025Lower Price Target$424.64$475.00Equal Weight$0.0000.00% ROIFTREFortrea3/4/2025Lower Price Target$10.38$12.00Equal Weight$0.0000.00% ROICERTCertara2/28/2025Boost Price Target$11.87$13.00Equal Weight$0.0000.00% ROISHCSotera Health2/28/2025Lower Price Target$12.47$16.00Overweight$0.0000.00% ROIICLRIcon2/21/2025Lower Price Target$201.84$240.00Overweight$0.0000.00% ROISHCSotera Health2/18/2025Lower Price Target$13.48$17.00Overweight$0.0000.00% ROICRLCharles River Laboratories International2/18/2025Lower Price Target$152.07$166.00Equal Weight$0.0000.00% ROIAAgilent Technologies2/10/2025Upgrade$145.21$145.00Equal Weight$0.0000.00% ROIWATWaters2/10/2025Upgrade$408.96$415.00Equal Weight$0.0000.00% ROIAVTRAvantor2/10/2025Lower Price Target$19.15$23.00Overweight$0.0000.00% ROITXG10x Genomics2/10/2025Lower Price Target$14.25$18.00Overweight$0.0000.00% ROITWSTTwist Bioscience2/3/2025Set Price Target$41.31$58.00Overweight$0.0000.00% ROIAVTRAvantor2/3/2025Boost Price Target$22.15$26.00Overweight$0.0000.00% ROIIQVIQVIA2/3/2025Lower Price Target$200.31$235.00Overweight$0.0000.00% ROIDHRDanaher1/30/2025Lower Price Target$223.12$240.00Equal Weight$0.0000.00% ROIEXASExact Sciences1/23/2025Initiated Coverage$54.79$70.00Overweight$0.0000.00% ROIGHGuardant Health1/23/2025Initiated Coverage$47.20$60.00Overweight$0.0000.00% ROINTRANatera1/23/2025Initiated Coverage$171.93$200.00Overweight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.